Functional role, mechanisms of regulation, and therapeutic potential of regulator of G protein signaling 2 in the heart

Trends in Cardiovascular Medicine

Volumn 24, Issue 2, 2014, Pages 85-93

  Zhang, Peng ^a   Mende, Ulrike ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RGS2 PROTEIN;

AORTA CONSTRICTION; BLOOD PRESSURE REGULATION; BLOOD VESSEL TONE; CARDIOVASCULAR DISEASE; CELLULAR DISTRIBUTION; HEART; HEART ARRHYTHMIA; HEART RATE; HEART VENTRICLE HYPERTROPHY; HUMAN; KIDNEY TRANSPLANTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; REVIEW; SIGNAL TRANSDUCTION; VASCULAR RESISTANCE; VASCULAR SMOOTH MUSCLE;

ANIMALS; CARDIOVASCULAR DISEASES; HUMANS; MOLECULAR TARGETED THERAPY; MYOCARDIUM; RGS PROTEINS; SIGNAL TRANSDUCTION;

EID: 84891937990     PISSN: 10501738     EISSN: 18732615     Source Type: Journal    
DOI: 10.1016/j.tcm.2013.07.002     Document Type: Review

References (71)

1. q-mediated signaling. Journal of Biological Chemistry 2004, 276:3906-3915.
2. Bansal G., Druey K.M., Xie Z. R4 RGS proteins: regulation of G-protein signaling and beyond. Pharmacology and Therapeutics 2007, 116:473-495.
3. i subfamily of G protein α subunits. Cell 1996, 86:445-452.
4. q/11α signaling. Journal of Biological Chemistry 2004, 279:21248-21256.
5. Bodenstein J., Sunahara R.K., Neubig R.R. N-terminal residues control proteasomal degradation of RGS2, RGS4, and RGS5 in human embryonic kidney 293 cells. Molecular Pharmacology 2007, 71:1040-1050.
6. Chakir K., Daya S.K., Aiba T., Tunin R.S., Dimaano V.L., Abraham T.P., et al. Mechanisms of enhanced β-adrenergic reserve from cardiac resynchronization therapy. Circulation 2009, 119:1231-1240.
7. i signaling. Journal of Molecular and Cellular Cardiology 2011, 50:1000-1007.
8. 2-adrenergic receptor signaling from restoring synchronous contraction in the failing heart. Science Translational Medicine 2012, 3:100ra88.
9. 11 signaling. Journal of Biological Chemistry 2001, 276:5438-5444.
10. Grant S.L., Lassegue B., Griendling K.K., Ushio-Fukai M., Lyons P.R., Alexander R.W. Specific regulation of RGS2 messenger RNA by angiotensin II in cultured vascular smooth muscle cells. Molecular Pharmacology 2000, 57:460-467.
11. Gu S., He J., Ho W.T., Ramineni S., Thal D.M., Natesh R., et al. Unique hydrophobic extension of the RGS2 amphipathic helix domain imparts increased plasma membrane binding and function relative to other RGS R4/B subfamily members. Journal of Biological Chemistry 2007, 282:33064-33075.
12. Gu S., Anton A., Salim S., Blumer K.J., Dessauer C.W., Heximer S.P. Alternative translation initiation of human regulators of G-protein signaling-2 yields a set of functionally distinct proteins. Molecular Pharmacology 2008, 73:1-11.
13. q. Molecular Pharmacology 2008, 73:1037-1043.
14. Gu S., Cifelli C., Wang S., Heximer S.P. RGS proteins: identifying new GAPs in the understanding of blood pressure regulation and cardiovascular function. Clinical Science (London, England: 1979) 2009, 116:391-399.
15. Gurley S.B., Griffiths R.C., Mendelsohn M.E., Karas R.H., Coffman T.M. Renal actions of RGS2 control blood pressure. Journal of the American Society of Nephrology 2010, 21:1847-1851.
16. Hao J., Michalek C., Zhang W., Zhu M., Xu X., Mende U. Regulation of cardiomyocyte signaling by RGS proteins: differential selectivity towards G proteins and susceptibility to regulation. Journal of Molecular and Cellular Cardiology 2006, 41:51-61.
17. Hendriks-Balk M.C., Peters S.L., Michel M.C., Alewijnse A.E. Regulation of G protein-coupled receptor signalling: focus on the cardiovascular system and regulator of G protein signalling proteins. European Journal of Pharmacology 2008, 585:278-291.
18. Heo K., Ha S.H., Chae Y.C., Lee S., Oh Y.S., Kim Y.H., et al. RGS2 promotes formation of neurites by stimulating microtubule polymerization. Cellular Signalling 2006, 18:2182-2192.
19. qα. Proceedings of the National Academy of Sciences of the United States of America 1997, 94:428-432.
20. qα function. Proceedings of the National Academy of Sciences of the United States of America 1997, 94:14389-14393.
21. Heximer S.P., Lim H., Bernard J.L., Blumer K.J. Mechanisms governing subcellular localization and function of human RGS2. Journal of Biological Chemistry 2001, 276:14195-14203.
22. Heximer S.P., Knutsen R.H., Sun X., Kaltenbronn K.M., Rhee M.H., Peng N., et al. Hypertension and prolonged vasoconstrictor signaling in RGS2-deficient mice. Journal of Clinical Investigation 2003, 111:445-452.
23. 2-adrenoceptor agonist-induced RGS2 expression is a genomic mechanism of bronchoprotection that is enhanced by glucocorticoids. Proceedings of the National Academy of Sciences of the United States of America 2011, 108:19713-19718.
24. Hollinger S., Hepler J.R. Cellular regulation of RGS proteins: modulators and integrators of G protein signaling. Pharmacological Reviews 2002, 54:527-559.
25. Ingi T., Krumins A.M., Chidiac P., Brothers G.M., Chung S., Snow B.E., et al. Dynamic regulation of RGS2 suggests a novel mechanism in G-protein signaling and neuronal plasticity. The Journal of Neuroscience 1998, 18:7178-7188.
26. Jensen K.P., Covault J. Human miR-1271 is a miR-96 paralog with distinct non-conserved brain expression pattern. Nucleic Acids Research 2011, 39:701-711.
27. Jones D.L., Tuomi J.M., Chidiac P. Role of cholinergic innervation and RGS2 in atrial arrhythmia. Frontiers in Physiology 2012, 3:239.
28. Kach J., Sethakorn N., Dulin N.O. A finer tuning of G-protein signaling through regulated control of RGS proteins. American Journal of Physiology. Heart and Circulatory Physiology 2012, 303:H19-H35.
29. Klaiber M., Kruse M., Volker K., Schroter J., Feil R., Freichel M., et al. Novel insights into the mechanisms mediating the local antihypertrophic effects of cardiac atrial natriuretic peptide: role of cGMP-dependent protein kinase and RGS2. Basic Research in Cardiology 2010, 105:583-595.
30. Koitabashi N., Kass D.A. Reverse remodeling in heart failure - mechanisms and therapeutic opportunities. Nature Reviews Cardiology 2012, 9:147-157.
31. Lohse M.J., Calebiro D. Cell biology: receptor signals come in waves. Nature 2013, 495:457-458.
32. Maillet M., van Berlo J.H., Molkentin J.D. Molecular basis of physiological heart growth: fundamental concepts and new players. Nature Reviews. Molecular Cell Biology 2013, 14:38-48.
33. Muinos-Gimeno M., Espinosa-Parrilla Y., Guidi M., Kagerbauer B., Sipila T., Maron E., et al. Human microRNAs miR-22, miR-138-2, miR-148a, and miR-488 are associated with panic disorder and regulate several anxiety candidate genes and related pathways. Biological Psychiatry 2011, 69:526-533.
34. q complex. Structure 2013, 21:438-448.
35. Nattel S. G-protein signaling and arrhythmogenic atrial remodeling: relevance to novel therapeutic targets in atrial fibrillation. Heart Rhythm 2009, 6:85-86.
36. Neitzel K.L., Hepler J.R. Cellular mechanisms that determine selective RGS protein regulation of G protein-coupled receptor signaling. Seminars in Cell and Developmental Biology 2006, 17:383-389.
37. Nguyen C.H., Ming H., Zhao P., Hugendubler L., Gros R., Kimball S.R., et al. Translational control by RGS2. Journal of Cell Biology 2009, 186:755-765.
38. Ni J., Qu L., Yang H., Wang M., Huang Y. Palmitoylation and its effect on the GTPase-activating activity and conformation of RGS2. The International Journal of Biochemistry and Cell Biology 2006, 38:2209-2218.
39. Osei-Owusu P., Sun X., Drenan R.M., Steinberg T.H., Blumer K.J. Regulation of RGS2 and second messenger signaling in vascular smooth muscle cells by cGMP-dependent protein kinase. Journal of Biological Chemistry 2007, 282:31656-31665.
40. i/o signaling. Journal of Biological Chemistry 2012, 287:12541-12549.
41. q/11-mediated signaling and hypertrophy in mice with cardiac-specific transgenic expression of regulator of G-protein signaling 2. PLoS One 2012, 7:e40048.
42. Qin M., Huang H., Wang T., Hu H., Liu Y., Gu Y., et al. Atrial tachyarrhythmia in Rgs5-null mice. PLoS One 2013, 7:e46856.
43. q signaling in osteoblasts. Journal of Biological Chemistry 2006, 281:32684-32693.
44. Salim S., Sinnarajah S., Kehrl J.H., Dessauer C.W. Identification of RGS2 and type V adenylyl cyclase interaction sites. Journal of Biological Chemistry 2003, 278:15842-15849.
45. 2+ channel TRPV6. Journal of Biological Chemistry 2006, 281:29669-29674.
46. Sethakorn N., Yau D.M., Dulin N.O. Non-canonical functions of RGS proteins. Cellular Signalling 2010, 22:1274-1281.
47. Shukla A.K., Xiao K., Lefkowitz R.J. Emerging paradigms of β-arrestin-dependent seven transmembrane receptor signaling. Trends in Biochemical Sciences 2011, 36:457-469.
48. Sinnarajah S., Dessauer C.W., Srikumar D., Chen J., Yuen J., Yilma S., et al. RGS2 regulates signal transduction in olfactory neurons by attenuating activation of adenylyl cyclase III. Nature 2001, 409:1051-1055.
49. Sjögren B., Blazer L.L., Neubig R.R. Regulators of G protein signaling proteins as targets for drug discovery. Progress in Molecular Biology and Translational Science 2010, 91:81-119.
50. Sjögren B., Neubig R.R. Thinking outside of the "RGS box": new approaches to therapeutic targeting of regulators of G protein signaling. Molecular Pharmacology 2010, 78:550-557.
51. Sjögren B., Parra S., Heath L.J., Atkins K.B., Xie Z.J., Neubig R.R. Cardiotonic steroids stabilize regulator of G protein signaling 2 protein levels. Molecular Pharmacology 2012, 82:500-509.
52. Stewart A., Huang J., Fisher R.A. RGS proteins in heart: brakes on the vagus. Frontiers in Physiology 2012, 3:95.
53. Sullivan B.M., Harrison-Lavoie K.J., Marshansky V., Lin H.Y., Kehrl J.H., Ausiello D.A., et al. RGS4 and RGS2 bind coatomer and inhibit COPI association with Golgi membranes and intracellular transport. Molecular Biology of the Cell 2000, 11:3155-3168.
54. Sun X., Kaltenbronn K.M., Steinberg T.H., Blumer K.J. RGS2 is a mediator of nitric oxide action on blood pressure and vasoconstrictor signaling. Molecular Pharmacology 2005, 67:631-639.
55. Tadevosyan A., Vaniotis G., Allen B.G., Hebert T.E., Nattel S. G protein-coupled receptor signalling in the cardiac nuclear membrane: evidence and possible roles in physiological and pathophysiological function. The Journal of Physiology 2012, 590:1313-1330.
56. Takimoto E., Koitabashi N., Hsu S., Ketner E.A., Zhang M., Nagayama T., et al. Regulator of G protein signaling 2 mediates cardiac compensation to pressure overload and antihypertrophic effects of PDE5 inhibition in mice. Journal of Clinical Investigation 2009, 119:408-420.
57. Tang M., Wang G., Lu P., Karas R.H., Aronovitz M., Heximer S.P., et al. Regulator of G-protein signaling-2 mediates vascular smooth muscle relaxation and blood pressure. Nature Medicine 2003, 9:1506-1512.
58. Tsingotjidou A., Nervina J.M., Pham L., Bezouglaia O., Tetradis S. Parathyroid hormone induces RGS-2 expression by a cyclic adenosine 3',5'-monophosphate-mediated pathway in primary neonatal murine osteoblasts. Bone 2002, 30:677-684.
59. 3 muscarinic receptor function and sensitivity to atrial arrhythmia in the RGS2-deficient mouse. American Journal of Physiology. Heart and Circulatory Physiology 2010, 298:H554-H561.
60. Van Rooij E., Marshall W.S., Olson E.N. Toward microRNA-based therapeutics for heart disease: the sense in antisense. Circulation Research 2008, 103:919-928.
61. Violin J.D., Soergel D.G., Boerrigter G., Burnett J.C., Lark M.W. GPCR-biased ligands as novel heart failure therapeutics. Trends in Cardiovascular Medicine 2013, (Epub ahead of print).
62. 2+ signalling by binding the N-terminal domain of RGS2 and the third intracellular loop of G-protein-coupled receptors. Nature Cell Biology 2005, 7:405-411.
63. Wettschureck N., Offermanns S. Mammalian G proteins and their cell type specific functions. Physiological Reviews 2005, 85:1159-1204.
64. Wolff D.W., Xie Y., Deng C., Gatalica Z., Yang M., Wang B., et al. Epigenetic repression of regulator of G-protein signaling 2 promotes androgen-independent prostate cancer cell growth. International Journal of Cancer 2012, 130:1521-1531.
65. Xie Z., Liu D., Liu S., Calderon L., Zhao G., Turk J., et al. Identification of a cAMP-response element in the regulator of G-protein signaling-2 (RGS2) promoter as a key cis-regulatory element for RGS2 transcriptional regulation by angiotensin II in cultured vascular smooth muscles. Journal of Biological Chemistry 2011, 286:44646-44658.
66. Yang J., Kamide K., Kokubo Y., Takiuchi S., Tanaka C., Banno M., et al. Genetic variations of regulator of G-protein signaling 2 in hypertensive patients and in the general population. Journal of Hypertension 2005, 23:1497-1505.
67. q/11-mediated signaling and cell proliferation in adult rat ventricular fibroblasts. The FASEB Journal 2008, 22(588):2.
68. Zhang P., Mende U. Regulators of G-protein signaling in the heart and their potential as therapeutic targets. Circulation Research 2011, 109:320-333.
69. Zhang P., Su J., King M.E., Maldonado A.E., Park C., Mende U. Regulator of G protein signaling 2 is a functionally important negative regulator of angiotensin II-induced cardiac fibroblast responses. American Journal of Physiology. Heart and Circulatory Physiology 2011, 301:H147-H156.
70. q/11 signaling by RGS2 protein exacerbates cardiomyocyte hypertrophy. Journal of Biological Chemistry 2006, 281:5811-5820.
71. 1-adrenergic activation in cultured ventricular myocytes. Cellular Signalling 2006, 18:1655-1663.